September 11, 2015

Repatha is one in a new class of cholesterol medications called PSCK9 (proprotein convertase substilisin kexin type 9) inhibitors, which are potentially an alternative to statins.

September 10, 2015

The acquisition of Diplomat's compounding pharmacy assets by Restore Health enables Diplomat to continue their singular focus on specialty pharmacy, the companies stated. 

August 21, 2015

Diplomat Pharmacy’s summer internship and fellowship program saw 10 fellows and 25 interns spend 12 weeks gaining hands-on experience in different departments of the specialty pharmacy. 

August 14, 2015

Keveyis is the first medicine approved by the FDA for the treatment of primary periodic paralysis, which is estimated to affect approximately 5,000 people in the United States.

August 4, 2015

As much as $91 million of revenue from new drugs helped drive a 49% increase in sales and a 19% increase in prescriptions dispensed through Diplomat. 

July 24, 2015

Diplomat Pharmacy has partnered with Pharmaca Integrative Pharmacy to offer Pharmaca patients access to specialty pharmacy services.

July 7, 2015

Phil Hagerman, CEO and Chairman of Diplomat Pharmacy, Inc., joined attendees as a special guest speaker for a “Specialty Lunch and Learn,” at McKesson’s ideaShare 2015. “Specialty is the new pharmacy,” Hagerman said.

June 22, 2015

Diplomat Pharmacy announced Friday that it had acquired the Pennsylvania-based Burman’s Specialty Pharmacy, which will expand Diplomat’s hepatitis C specialty services. 

May 12, 2015

Total prescriptions dispensed by Diplomat Pharmacy were up 6% to 194,000 in the first quarter.

April 22, 2015

The past year has been eventful for Diplomat.

April 20, 2015

Specialty pharmacy operator Diplomat Pharmacy is on the lookout for a few good students, the company announced Friday. 

April 17, 2015

Diplomat Pharmacy on Thursday named a long-time data security veteran to the chief information security officer post. 

April 14, 2015

Diplomat Pharmacy announced it will distribute Novartis' new medicine Jadenu, which is indicated to treat patients with chronic iron overload. 

April 3, 2015

Diplomat Pharmacy on Friday celebrated 40 years of service. 

April 2, 2015

Diplomat Pharmacy on Wednesday completed its acquisition of BioRx. 

April 1, 2015

Diplomat Pharmacy raised almost $200 million in follow-on public offering that closed Tuesday. 

March 24, 2015

Diplomat Pharmacy commences follow-on public offering of 7.4 million shares of its common stock.

March 18, 2015

Diplomat Pharmacy to offer PARI’s cystic fibrosis treatment Kitabis Pak together with a PARI LC Plus nebulizer handset.

March 16, 2015

Diplomat Pharmacy is looking to raise $200 million with a proposed follow-on public offering of its common stock.

February 26, 2015

Diplomat Pharmacy on Thursday acquired the specialty pharmacy BioRx.


February 25, 2015

Diplomat Pharmacy to dispense new multiple myeloma treatment from Novartis. 

February 23, 2015

Diplomat Pharmacy's Phil and Jocelyn Hagerman gift $5 million to the Ferris State University’s College of Pharmacy. 

February 3, 2015

Diplomat Pharmacy announced Monday that it has earned the Verified Internet Pharmacy Practice Sites seal of approval from the National Association of Boards of Pharmacy.

January 30, 2015

Diplomat Pharmacy announced Thursday that the Food and Drug Administration has approved an expanded indication of Imbruvica (ibrutinib) for the treatment of Waldenström’s macroglobulinemia (WM).